Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Liberty One Investment Management LLC

Liberty One Investment Management LLC increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 35.6% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,861 shares of the medical equipment provider's stock after purchasing an additional 489 shares during the quarter. Liberty One Investment Management LLC's holdings in Intuitive Surgical were worth $922,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the business. Brighton Jones LLC increased its stake in Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after buying an additional 731 shares in the last quarter. Bank Pictet & Cie Europe AG increased its stake in Intuitive Surgical by 0.5% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock worth $99,678,000 after buying an additional 883 shares in the last quarter. Proficio Capital Partners LLC increased its stake in Intuitive Surgical by 70.9% during the 4th quarter. Proficio Capital Partners LLC now owns 1,820 shares of the medical equipment provider's stock worth $950,000 after buying an additional 755 shares in the last quarter. Ashton Thomas Private Wealth LLC increased its stake in Intuitive Surgical by 153.5% during the 4th quarter. Ashton Thomas Private Wealth LLC now owns 2,241 shares of the medical equipment provider's stock worth $1,170,000 after buying an additional 1,357 shares in the last quarter. Finally, Lifeworks Advisors LLC purchased a new stake in Intuitive Surgical during the 4th quarter worth approximately $222,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Trading Down 2.7%

Intuitive Surgical stock traded down $13.99 during mid-day trading on Friday, hitting $512.06. The company's stock had a trading volume of 2,951,229 shares, compared to its average volume of 1,679,961. The firm has a market capitalization of $183.53 billion, a PE ratio of 75.08, a price-to-earnings-growth ratio of 5.58 and a beta of 1.64. Intuitive Surgical, Inc. has a 1 year low of $413.82 and a 1 year high of $616.00. The stock's fifty day moving average is $537.85 and its two-hundred day moving average is $536.69.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same period in the prior year, the business posted $1.50 earnings per share. On average, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Gary Loeb sold 1,700 shares of the company's stock in a transaction on Friday, April 25th. The stock was sold at an average price of $513.18, for a total transaction of $872,406.00. Following the transaction, the executive vice president directly owned 2,245 shares in the company, valued at $1,152,089.10. This represents a 43.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Mark Brosius sold 216 shares of the company's stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the transaction, the senior vice president owned 907 shares in the company, valued at $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 4,998 shares of company stock valued at $2,611,577 over the last three months. 0.70% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the company. Truist Financial cut their price objective on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research note on Wednesday, April 23rd. Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Thursday, June 5th. Citigroup restated a "buy" rating and issued a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Royal Bank Of Canada dropped their price target on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research report on Wednesday, April 23rd. Finally, BTIG Research set a $560.00 price target on Intuitive Surgical and gave the company a "buy" rating in a research report on Monday, April 14th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $592.59.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.